A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.
Maekawa N, Konnai S, Takagi S, Kagawa Y, Okagawa T, Nishimori A, Ikebuchi R, Izumi Y, Deguchi T, Nakajima C, Kato Y, Yamamoto K, Uemura H, Suzuki Y, Murata S, Ohashi K.
Maekawa N, et al. Among authors: ikebuchi r.
Sci Rep. 2017 Aug 21;7(1):8951. doi: 10.1038/s41598-017-09444-2.
Sci Rep. 2017.
PMID: 28827658
Free PMC article.